Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States

Infection Control and Hospital Epidemiology

Volumn 29, Issue 12, 2008, Pages 1157-1163

  Patel, Mitesh S ^a   Gebremariam, Achamyeleh ^a   Davis, Matthew M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; HERPES ZOSTER; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MEDICARE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; HERPES ZOSTER; HOSPITAL CHARGES; HOSPITALIZATION; HUMANS; INFANT; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 56749156027     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/591975     Document Type: Article

References (28)

1. Gnann JW Jr, Whitley RJ. Herpes zoster. N Engl J Med 2002; 347:340-346.
2. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352:2266-2267.
3. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32:1481-1486.
4. Seward JF, Watson BM, Peterson CL, et al. Varicella diseases after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287:606-611.
5. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005; 294:797-802.
6. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the united states. Pediatrics 2004; 114:786-792.
7. Vázquez M, Shapiro ED. Varicella vaccine and infection with varicella-zoster virus. N Engl J Med 2005; 352:439-440.
8. Edmunds WJ, Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J Infect 2002; 44:211-219.
9. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20:2500-2507.
10. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005; 191:2002-2007.
11. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005; 133:245-253.
12. Centers for Disease Control and Prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2008; 57(RR-5):1-30.
13. Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization in Project (HCUP). Agency for Healthcare Research and Quality; 2006. Available at: http://www.ahrq.gov/data/hcup/. Accessed April 30, 2007.
14. US Census Bureau, Administrative and Customer Services Division, Statistical Compendia Branch. Statistical abstract of the United States. Available at: http://www.census.gov/statab/www/. Accessed May 15, 2007.
15. US Department of Labor, Bureau of Labor Statistics. Consumer price index. Available at: http://www.bls.gov/cpi/home.htm. Accessed May 15, 2007.
16. Coplan R, Black S, Rojas C, et al. Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J 2001; 20:641-645.
17. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995; 155:1605-1609.
18. Centers for Disease Control and Prevention. Estimated vaccination coverage with individual vaccine and selected vaccination series among children 19-35 months of age by state - Q1/1996-Q4/1996. Available at: http://www.cdc.gov/vaccines/stats-surv/nis/data/tables_1996.htm. Accessed November 8, 2007.
19. Centers for Disease Control and Prevention. Estimated vaccination coverage with individual vaccine and selected vaccination series among children 19-35 months of age by state - Q1/2004-Q4/2004. http://www.cdc.gov/vaccines/ stats-surv/nis/data/tables_2004.htm. Accessed November 8, 2007.
20. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes-zoster in adults: a case-control study. Lancet 2002; 360:678-682.
21. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005; 352:450-458.
22. Wagenpfeil S, Neiss A, Wutzler P. Effects of varicella vaccination on herpes zoster incidence. Clin Microbiol Infect 2004; 10:954-960.
23. Lin F, Hadler JL. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis 2000; 181:1897-1905.
24. Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine in healthy children: a study in children with leukemia. N Engl J Med 1991; 325:1545-1550.
25. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007; 356:1338-1343.
26. Centers for Disease Control and Prevention. Adult vaccine price list. Available at: http://www.cdc.gov/vaccines/programs/vfc/cdc-vac-pricelist. htm#adult. Accessed November 8, 2007.
27. Hornberger J, Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med 2006; 145:317-325.
28. Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 2007; 44:1280-1288.